Luye Pharma Group Ltd Stock Singapore S.E.
Equities
LUYE
BMG5722Z1014
Pharmaceuticals
Sales 2023 | 6.14B 849M 1.15B 1.16B | Sales 2024 * | 6.79B 938M 1.27B 1.28B | Capitalization | 10.52B 1.45B 1.96B 1.99B |
---|---|---|---|---|---|
Net income 2023 | 533M 73.62M 99.46M 101M | Net income 2024 * | 658M 90.89M 123M 124M | EV / Sales 2023 | 2.08 x |
Net Debt 2023 * | 3.67B 507M 685M 694M | Net Debt 2024 * | 2.95B 407M 550M 557M | EV / Sales 2024 * | 1.98 x |
P/E ratio 2023 |
23.7
x | P/E ratio 2024 * |
17.3
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 51.84% |
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 94-06-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 94-06-07 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |